Page last updated: 2024-10-22

amitriptyline and Combat Disorders

amitriptyline has been researched along with Combat Disorders in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Combat Disorders: Neurotic reactions to unusual, severe, or overwhelming military stress.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kudler, HS1
Davidson, JR1
Stein, R1
Erickson, L1
Falcon, S1
Ryan, C1
Chamberlain, K1
Curtis, G1

Trials

2 trials available for amitriptyline and Combat Disorders

ArticleYear
Measuring results of treatment of PTSD.
    The American journal of psychiatry, 1989, Volume: 146, Issue:12

    Topics: Amitriptyline; Clinical Trials as Topic; Combat Disorders; Desipramine; Double-Blind Method; Humans;

1989
Tricyclics: possible treatment for posttraumatic stress disorder.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:9

    Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Combat Disorders;

1985